| ¿µ¹® | valve | ÇÑ±Û | ÆÇ¸· |
|---|---|---|---|
| ¼³¸í | °ü ȤÀº Åë·Î¿¡ ÀÖ´Â ¸·°ú °°Àº ÁÖ¸§. ³»¿ë¹°ÀÇ ¿ª·ù¸¦ ¸·´Â´Ù. 1.½ÉÀåÆÇ¸·: ¿ì½É¹æ°ú ¿ì½É½Ç»çÀÌÀÇ »ï÷ÆÇ, Á½ɹæ°ú Á½ɽǻçÀÌÀÇ ½Â¸ðÆÇ, ¿ì½É½Ç°ú Æóµ¿¸Æ»çÀÌÀÇ Æóµ¿¸Æ¹Ý¿ùÆÇ, Á½ɽǰú ´ëµ¿¸Æ»çÀÌÀÇ ´ëµ¿¸Æ¹Ý¿ùÆÇÀÌ ÀÖ´Ù. 2.Á¤¸ÆÆÇ¸·: Á¤¸Æ¿¡¼ ¹ß°ßµÇ´Â ³»¸·ÀÇ ÀÛÀº ÷ ȤÀº ÁÖ¸§. ź·Â¼ºÀÌ Àû¾î ¿ª·ùµÇ±â ½¬¿î Á¤¸ÆÇ÷ÀÇ È帧À» ¿ª·ù¾øÀÌ Á¤»óÀûÀÎ ¹æÇâÀ¸·Î Áö¼ÓµÇµµ·Ï ÇØÁØ´Ù. 3.ÀΰøÆÇ¸·: ½ÉÀåÆÇ¸·ºÎÁ·À̳ª ½ÉÀåÆÇ¸·ÇùÂøÀÌ ÀÖ¾î ´õÀÌ»ó ÀÚ½ÅÀÇ ÆÇ¸·À¸·Î´Â »ýÁ¸ÀÌ ºÒ°¡´ÉÇÒ ¶§ ´ë½Å À̽ÄÇÏ°Ô µÇ´Â ÀΰøÆÇ¸·À» ¸»ÇÑ´Ù. Å©°Ô µ¿¹°ÀÇ Á¶Á÷À» ÀÌ¿ëÇÑ °Í°ú ±×·¸Áö ¾ÊÀº °ÍÀ¸·Î ¾çºÐÇÒ ¼ö ÀÖ´Ù. µ¿¹°ÀÇ Á¶Á÷À» ÀÌ¿ëÇÑ °ÍÀº ÁÖ·Î µÅÁö³ª ¼ÒÀÇ ÆÇ¸· ¶Ç´Â ½É¿Ü¸· µîÀ» ÀÌ¿ëÇϸç, ±×·¸Áö ¾ÊÀº °ÍÀº Ư¼öÇÑ ±Ý¼ÓÀ» ÀÌ¿ëÇÏ¿© ¸¸µç´Ù. |
||
| ¿µ¹® | variant | ÇÑ±Û | º¯Çü, º¯ÀÌ |
|---|---|---|---|
| ¼³¸í | 1.¼Ò¼ÓÇÏ´Â ºÎ·ù¿Í ´Ù¸¥ ¼ºÁúÀ» °®´Â °ÍÀÇ ÃÑĪ, ¶Ç´Â ÀϺΠƯº°ÇÑ ¼ºÁú¸¸ Ʋ¸®´Â °Í¿¡ »ç¿ëµÇ´Â ´Ü¾î. 2. »ý¹°ÇÐ»ó µ¿Á¾ÀÇ »ý¹°¿¡¼ º¼ ¼ö ÀÖ´Â ÇüÁúÀÇ Â÷ÀÌ. |
||
| ¿µ¹® | varicose vein | ÇÑ±Û | Á¤¸Æ·ù¼ºÁ¤¸Æ |
|---|---|---|---|
| ¼³¸í | È®ÀåµÇ°í ´Ã¾î³ Á¤¸ÆÀ¸·Î ÀϹÝÀûÀ¸·Î ³Ò´Ù¸®ÀÇ ÇÇÇÏÁ¶Á÷¿¡¼ º¼ ¼ö ÀÖÀ¸¸ç, Á¤¸ÆÆÇÀÇ ºÎÁ·À» µ¿¹ÝÇÑ´Ù. ±Ùº»ÀûÀÎ Ä¡·á´Â È®ÀåµÈ Á¤¸Æ·ùÀÇ ÀýÁ¦ÀÌ´Ù. |
||
| ¿µ¹® | variola | ÇÑ±Û | ¸¶¸¶, µÎâ |
|---|---|---|---|
| ¼³¸í | ¸¶¸¶¹ÙÀÌ·¯½º(poxvirus)¿¡ ÀÇÇØ¼ ÀϾ´Â ±Þ¼º¹ýÁ¤ Àü¿°º´. Àẹ±â´Â 12ÀÏÀ̰í, ÀÌ¾î¼ À̻󼺹߿°æ°ú°¡ ½ÃÀ۵ȴÙ. Á¦1±â´Â 3~4ÀÏ °è¼ÓµÇ´Âµ¥ ÀÌ ±â°£¿¡ ¹ß¿°ú 1°ú¼º È«¹Ý, ¶Ç´Â Á¡ÃâÇ÷¹ÝÀÌ ±¸°£¿¡ »ý±ä´Ù. ±×°ÍÀÌ ¼Ò¸êµÇ°í ü¿ÂÀÌ ÀÏÀϰ£ ÇϰÇϳª, ÀÌ¾î¼ ´Ù½Ã »ó½ÂÇϸç À̶§¿¡ ±¸ÁøÀÌ ¾ó±¼, ¼Õ, ¹ß¿¡ ³ªÅ¸³ª¼ ¼öÆ÷ȵǰí, ±Þ¼ÓÈ÷ ³óÆ÷»óÀ¸·Î µÈ´Ù. º´º¯Àº ¼Õ¹Ù´Ú, ¹ß¹Ù´Ú, ÆÈ´Ù¸®ÀÇ ¿øÀ§ºÎ¿¡¼ ±¸°£À» ÇâÇØ¼ ÁøÇàµÈ´Ù. °¢ º´º¯Àº Á¤È®ÇÏ°Ô °°Àº Å©±â¿Í ¹ß»ý½Ã±â°¡ °°Àº º´º¯À¸·Î µÑ·¯½ÎÀ̸ç, ÁÖ·Î ¸öÀÇ ³íÃâºÎ¿¡ ³ªÅ¸³ª°í, °Üµå¶û, »ô°í¶û¿¡´Â ³ªÅ¸³ªÁö ¾Ê´Â´Ù. ³óÆ÷´Â Á߽ɺΰ¡ ÇÔ¸ôµÇ°í, µüÁö¸¦ Çü¼ºÇϸç 7~10ÀÏ ÈÄ¿¡ Å»¶ôµÇ¾î, ÀÛÀº ÇÔ¿ä, Å»»öµÈ ¹ÝÈçÀ» ³²±ä´Ù. ´Ù¸¥ Áõ»óÀ¸·Î Æó·Å, °üÀý¿°, °ñ¼ö¿°, ÇǺΠ¹× ±¸° Á¡¸·º´º¯ÀÇ ÃâÇ÷ÀÌ Æ÷ÇԵȴÙ. µîÂÊÅëÁõ, µÎÅë ¹× ¼è¾àÀÌ ÈçÈ÷ ¼ö¹ÝµÈ´Ù. |
||
| V/S | Vital Signs; Ȱ·ÂÁõÈÄ 1. Body Temperature; ü¿Â 2. Blood Pressure; Ç÷¾Ð 3. Heart Rate; ½É¹Ú¼ö 4. Respiratory; È£Èí¼ö |
|---|---|
| v/v | percent volume in volume |
| v/w | volume per weight |
| V1 TP V6 | ventral 1 to ventral 6 [chest leads in ECG] |
| VA | vacuum aspiration; valproic acid; vasodilator agent; ventricular aneurysm; ventricular arrhythmia; ventriculoatrial; ventroanterior; vertebral artery; Veterans Administration; Veterans Affairs; vincristine, adriamycin; viral antigen; visual acuity; visual aid; visual axis; volt-ampere; volume-average |
| VA | alveolar ventilation |
| Va | alveolar ventilation |
| VA shunt | Ventriculo-Atrial shunt |
| Va/Q | alveolar ventilation/perfusion |
| VA/QC | ventilation-perfusion [ratio] |
| vaccinate | To administer a vaccine. (05 Mar 2000) |
|---|---|
| vaccination | <procedure> The introduction of vaccine into the body for the purpose of inducing immunity. Coined originally to apply to the injection of smallpox vaccine, the term has come to mean any immunising procedure in which vaccine is injected. Origin: L. Vacca = cow (18 Nov 1997) |
| vaccination, anthrax | A series of six shots over six months and booster shots annually, the anthrax vaccine now in use in the usa was first developed in the 1950s and approved by the food and drug administration for general use in 1970. It is produced by the michigan biologic products institute of michigan's department of health and is given routinely to veterinarians and others working with livestock. In december, 1997 it was announced that all us military would receive the vaccine, as do the military in the uk and russia, the reason being concern that anthrax might be used in biologic warfare. (12 Dec 1998) |
| vaccination, chickenpox | This vaccine prevents the common disease known as chickenpox (varicella zoster). While chickenpox is often considered a trivial illness, it can cause significant lost time on the job and in school and have serious complications including ear infections, pneumonia, and infection of the rash with bacteria, inflammation of the brain (encephalitis) leading to difficulty with balance and coordination (cerebellar ataxia), damaged nerves (palsies), and reye's syndrome, a potentially fatal complication. The vaccination requires only one shot given at about a year of age. If an older person has not had chickenpox, the shot may be given at any time. There have been few significant reactions to the chickenpox vaccine. All children, except those with a compromised immune system, should have the vaccination. (12 Dec 1998) |
| vaccination, children's | In the United States, it is recommended that all children receive vaccination against: - hepatitis b - diphtheria, tetanus, pertussis - haemophilus influenzae type b (hib), poliovirus, measles, mumps, rubella, varicella zoster virus (chickenpox). Every child in the u.s. Should have these vaccinations except when there are special circumstances and the child's doctor advises specifically against a vaccination. (12 Dec 1998) |
| vaccination, dpt | DPT immunization protects from diphtheria, pertussis (whooping cough), and tetanus and is given in a series of 5 shots at 2, 4, 6, 18 months of age and 4-6 years of age. Thanks to vaccination programs, these diseases have become less common. However, there are still unvaccinated individuals capable of carrying and passing diphtheria and pertussis to others who are not vaccinated. Tetanus bacteria are prevalent in natural surroundings, such as contaminated soil. See also vaccination, dtap. (12 Dec 1998) |
| vaccination, dt | DT (diphtheria and tetanus) vaccine does not protect from pertussis and is usually reserved for individuals who have had a significant adverse reaction to a dpt shot or who have a personal or family history of a seizure disorder or brain disease (12 Dec 1998) |
| vaccination, dtap | Like DPT, DTaP protects from diphtheria, pertussis (whooping cough) and tetanus. Dtap is the same as dtp, except that it contains only acellular pertussis vaccine which is thought to cause fewer of the minor reactions associated with immunization and is also probably less likely to cause the more severe reactions occasionally seen following pertussis vaccination. Dtap is currently recommended only for the shots given at 18 months and 4-6 years of age. (12 Dec 1998) |
| vaccination, german measles | See Vaccination, MMR. (12 Dec 1998) |
| vaccination, haemophilus influenzae type b | See vaccination, hib. (12 Dec 1998) |
| vaccination, hepatitis a | When immediate protection against hepatitis a (infectious hepatitis) is needed, immunoglobulins are used. Protection is effective only if given within 2 weeks of exposure and lasts but 2-4 months. Immunoglobulins can be used to protect household contacts of someone with acute viral hepatitis and travelers to regions with poor sanitation and high hepatitis a rates, when the traveler has to depart sooner than the vaccines can take effect (about 2 weeks). Travelers can receive the immunoglobulin and vaccine simultaneously and be protected immediately and for longer term. When immediate protection is not needed, hepatitis a vaccines are considered for individuals in high-risk settings, including frequent world travelers, sexually active individuals with multiple partners, homosexual men, individuals using illicit drugs, employees of daycare centres, and certain health care workers, and sewage workers. Two hepatitis a vaccines called havrix and vaqta are commercially available in the u.s. Both are highly effective and provide protection even after only one dose. Two doses are recommended for adults and 3 doses for children (under 18 years of age) to provide prolonged protection. (12 Dec 1998) |
| vaccination, hepatitis b | Hepatits B (hep B) vaccine gives prolonged protection, but 3 shots over a half year are usually required. In the u.s., all infants receive hep b vaccine. Two vaccines (engerix-b, and recombivax-hb) are available in the us. The first dose of hep b vaccine is frequently given while the newborn is in the hospital or at the first doctor visit following birth. The second dose is given about 30 days after the initial dose. A booster dose is performed approximately six months later. Babies born to mothers testing positive for hep b receive, in addition, hbig (hep b immune globulin) for prompt protection. Older children (11-12 years) are advised to receive a hep b booster as are adults in high-risk situations including healthcare workers, dentists, intimate and household contacts of patients with chronic hep b infection, male homosexuals, individuals with multiple sexual partners, dialysis patients, iv drug users, and recipients of repeated transfusions. Health care workers accidentally exposed to materials infected with hep b (such as needle sticks), and individuals with known sexual contact with hep b patients are available in the u.s. Both are highly effective and provide protection even after only one dose. Two doses are recommended for adults and 3 doses for children (under 18 years of age) to provide prolonged protection. Vaccination, hepatitis b: hepatits b (hep b) vaccine gives prolonged protection, but 3 shots over a half year are usually required. In the u.s., all infants receive hep b vaccine. Two vaccines (engerix-b, and recombivax-hb) are available in the us. The first dose of hep b vaccine is frequently given while the newborn is in the hospital or at the first doctor visit following birth. The second dose is given about 30 days after the initial dose. A booster dose is performed approximately six months later. Babies born to mothers testing positive for hep b receive, in addition, hbig (hep b immune globulin) for prompt protection. Older children (11-12 years) are advised to receive a hep b booster as are adults in high-risk situations including healthcare workers, dentists, intimate and household contacts of patients with chronic hep b infection, male homosexuals, individuals with multiple sexual partners, dialysis patients, iv drug users, and recipients of repeated transfusions. Health care workers accidentally exposed to materials infected with hep b (such as needle sticks), and individuals with known sexual contact with hep b patients are usually given both hbig and vaccine to provide immediate and long term protection. (12 Dec 1998) |
| vaccination, hib | This vaccine is to prevent disease caused by the haemophilus influenzae type b (hib) bacteria. The h. Influenzae (h. Flu) bacteria can cause a range of serious diseases including meningitis with potential brain damage and epiglottitis with airway obstruction poisoning. The hib vaccine is usually given at 2, 4 and 6 months of age. A final booster is given at 12-15 months of age. Hib vaccine rarely causes severe reactions. (12 Dec 1998) |
| vaccination, infectious hepatitis | See Vaccination, hepatitis a. (12 Dec 1998) |
| vaccination, measles | See Vaccination, MMR. Vaccination, mmr: the standard vaccine given to prevent measles, mumps and rubella (german measles). The mmr vaccine is now given in two dosages. The first should be given at12-15 months of age. The second vaccination hould be given at 4-6 years (or, alternatively, 11-12 years) of age. most colleges require proof of a second measles or mmr vaccination prior to entrance. Most children should receive mmr vaccinations. Exceptions may include children born with an inability to fight off infection, some children with cancer, on treatment with radiation or drugs for cancer, on long term steroids (cortisone). People with severe allergic reactions to eggs or the drug neomycin should probably avoid the mmr vaccine. Pregnant women should wait until after delivery before being immunised with mmr. People with HIV or aids should normally receive mmr vaccine. Measles, mumps, and rubella vaccines may be administered as individual shots, if necessary, or as a measles-rubella combination. (12 Dec 1998) |
Synonyms : Inactivated Vaccines
Synonyms :
Synonyms : Subunit Vaccines
Synonyms : Synthetic Antigens, Synthetic Immunogens, Vaccines, Chemical, Vaccines, Molecular, Vaccines, Semisynthetic, Recombinant Vaccines
Synonyms : Virosome Vaccines
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
ºñŸ¾¾Á¤1000mg - »õâ
|
Çѱ¹À¯³ªÀÌÆ¼µåÁ¦¾à |
A12903261 | Ascorbic Acid | ÀϹÝÀǾàǰ | ±Þ¿© |
|
ºñŸ¾¾Á¤500mg - »õâ
|
Çѱ¹À¯³ªÀÌÆ¼µåÁ¦¾à |
A12902571 | Ascorbic Acid | ÀϹÝÀǾàǰ | »èÁ¦ |
|
ºñŸ¹Î¾¾Á¤ - »õâ
|
´ë¿õÁ¦¾à |
A04300111 | Ascorbic Acid | ÀϹÝÀǾàǰ | »èÁ¦ |
|
¹ÙÀÌÆä·ÑÁ¤ - »õâ
|
¼¿ïÁ¦¾à |
A37000941 | Ascorbic Acid, Fursultiamine, Pyridoxine HCl, Riboflavin, Tocopherol Acetate | ÀϹÝÀǾàǰ | ºñ±Þ¿© |
|
¹Ù·ÎÄÚ¹ÎÁ¤ - »õâ
|
½ÅdzÁ¦¾à |
A00303291 | Ascorbic Acid, Cyanocobalamin, Fursultiamine, Pyridoxine HCl, Riboflavin, Tocopherol Acetate | ÀϹÝÀǾàǰ | ºñ±Þ¿© |
|
¹ÙÀ̸®¹öݼ¿ - »õâ
|
¿µÀÏÁ¦¾à |
A16602621 | ATSO | ÀϹÝÀǾàǰ | ±Þ¿© |
|
¹Ù½ºÄÚݼ¿ - »õâ
|
¼¿ïÁ¦¾à |
A37001821 | ATSO | ÀϹÝÀǾàǰ | ±Þ¿© |
|
¹Ù½ºÅ¥¶óÆ®Á¤ - »õâ
|
Çѱ¹º£¸µ°ÅÀΰÖÇÏÀÓ |
A07600181 | Bamethan Sulfate | Àü¹®ÀǾàǰ | »èÁ¦ |
|
¾¾Á¦À̺ñŸ¸ÞÁøÄ°¼¿ - »õâ
|
¾¾Á¦ÀÌ |
A01002291 | Benfotiamine, Cyanocobalamin, Pyridoxine HCl | ÀϹÝÀǾàǰ | ºñ±Þ¿© |
|
¾¾Á¦À̺ñŸ¸ÞÁøÄ°¼¿50mg - »õâ
|
¾¾Á¦ÀÌ |
A01002301 | Benfotiamine, Cyanocobalamin, Pyridoxine HCl | ÀϹÝÀǾàǰ | ºñ±Þ¿© |
| visceral leishmaniasis |
leishmaniasis of the viscera
Ãâó: wordnet.princeton.edu/perl/webwn
|
|---|---|
| variability |
the quality of being subject to variation unevenness: the quality of being uneven and lacking uniformity
Ãâó: wordnet.princeton.edu/perl/webwn
|
| visceral pericardium |
epicardium: the innermost of the two layers of the pericardium
Ãâó: wordnet.princeton.edu/perl/webwn
|
| visualization |
visual image: a mental image that is similar to a visual perception
Ãâó: wordnet.princeton.edu/perl/webwn
|
| variable |
something that is likely to vary; something that is subject to variation; "the weather is one variable to be considered" liable to or capable of change; "rainfall in the tropics is notoriously variable"; "variable winds"; "variable expenses" a quantity that can assume any of a set of values variable star: a star that varies noticeably in brightness varying: marked by diversity or difference; "the varying angles of roof slope"; "nature is infinitely variable" a symbol (like x or y) that is used in mathematical or logical expressions to represent a variable quantity (used of a device) designed so that a property (as e.g. light) can be varied; "a variable capacitor"; "variable filters in front of the mercury xenon lights"
Ãâó: wordnet.princeton.edu/perl/webwn
|
| v | leave voluntarily |
|---|---|
| v | the act of making something legally void |
| v | leisure time away from work |
| v | spend or take a vacation |
| v | a dwelling (a second home) where you live while you are on vacation |
| v | an area where many people go for recreation |
| v | someone on vacation |
| v | the act of taking a vacation |
| v | someone on vacation |
| v | cow-cockles |
| v | European annual with pale rose-colored flowers |
| v | European annual with pale rose-colored flowers |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|